Kelun-Biotech is conducting Phase II China trials of the PD-L1 in patients with lymphoma and NPC. Harbour has R&D sites in Shanghai and Suzhou, headquarters in Boston and an antibody discovery ...
-
-
Recent Updates
- China Trade Talks Face New Uncertainty as US Freight Rates Stay High
- Nvidia CEO Jensen Huang Steps Down as China Spy Allegations Cloud AI Boom
- China’s Battery-Swapping E-Trucks Take Aim at Range Anxiety
- Hong Kong’s Central Draws Luxury Travelers With LANDMARK Celebration
- China: Singapore firm eyes healthcare growth in Shanghai – 75005001
- 2026 W China Annual Gala: A Tale of Two Cities in Shanghai
- China AI Firms Watch as Nvidia Suppliers Prepare for a Possible Huang Exit
- China AI Firms Watch as Nvidia Suppliers Prepare for a Possible Huang Exit
- Nvidia Succession Fears Hit China and Asian AI Supply Chains
- Nvidia Succession Fears Hit China and Asian AI Supply Chains
Blogroll